Like every year-end, Barron's analysts publish their list of the 10 most promising stocks for the coming year. This has become a tradition, and in 2025, their selections beat the S&P 500. For 2026, the list presents an interesting mix, ranging from tech giants to value opportunities, including sectors such as energy, healthcare, and entertainment.
The new year begins with a question every investor asks: where should capital be allocated to maximize returns over the next twelve months? Barron's, the historic American financial publication, has provided its answer with a selection that would be an understatement to call eclectic. Amazon tops the list, but the real surprise lies in the overall composition of the portfolio, which this year features a decidedly more value-oriented stance than in previous years.
The full list for 2026 includes Amazon, Bristol Myers Squibb, Comcast, Exxon Mobil, Fairfax Financial Holdings, Flutter Entertainment, Madison Square Garden Sports, SL Green Realty, Visa, and Walt Disney. This combination reflects a balanced view of growth and value, with a focus on stocks with compressed multiples relative to their potential.
Amazon: The Giant Ready for Redemption
Amazon finds itself in a peculiar position as we enter 2026. After a disappointing 2025, with its stock up just 6% against an S&P 500 that gained 18%, the Seattle giant is shaping up to be the worst-performing of the "Magnificent Seven" of the year. Yet, according to Barron's analysts, now is precisely the right time to position yourself.
The investment thesis is based on several pillars. Amazon Web Services showed signs of reacceleration in the third quarter of 2025, achieving 20% year-over-year growth, its fastest pace since 2022. JPMorgan analysts, led by Doug Anmuth, expect AWS to achieve growth of 23% or more by the end of 2026, driven by investments in AI infrastructure and proprietary Trainium chips.
Amazon remains a high-quality compounder with a 25% earnings CAGR, solid double-digit revenue growth, expanding operating margins, and free cash flow that is likely to expand materially over the next 24 months.
— Mark Mahaney, Evercore ISIAnalysts' average price target stands at around $295, implying an upside of approximately 27% from current levels. Evercore ISI's Mark Mahaney goes even further, setting a target of $335, which would represent a potential upside of 50%. Supporting this view is the recent $38 billion cloud deal with OpenAI, which could catalyze further demand for AWS as AI usage expands.
The stock is currently trading at approximately 29 times projected 2026 earnings, a multiple that may seem high but is surprisingly lower than Walmart's. Given the diversification of the business across e-commerce, cloud, advertising, and emerging ventures such as pharmaceutical services, the Leo (Project Kuiper) satellite, and the Zoox robotaxi, the risk-reward ratio appears favorable for those with a medium- to long-term horizon.
Walt Disney: The House of Mouse Aims for Relaunch
Disney enters 2026 with a strong performance on the streaming front and renewed strength in its Experiences segment. Its direct-to-consumer business has completed a remarkable transformation: from a $4 billion loss three years ago, the segment generated $1.3 billion in operating income in fiscal 2025, with the fourth quarter alone contributing $352 million.
The combined Disney+ and Hulu has reached 196 million subscribers, and management expects operating margins of 10% for 2026. The announcement of Hulu's full integration into Disney+ later this year represents a further step towards operational efficiency and a stronger value proposition for subscribers.
Bullish Catalysts for Disney in 2026
The film calendar looks packed with blockbusters like Avengers: Doomsday (expected to be the year's highest-grossing film), The Mandalorian and Grogu , and Toy Story 5. Disney produced the only three films to surpass $1 billion at the global box office in 2024, and that strength is expected to continue. On the Experiences front, the Disney Adventure cruise ship, the largest in the fleet, will set sail in early 2026.
The Experiences segment reported a record operating profit of $10 billion in fiscal 2025, up 8%. Despite the opening of Comcast's Epic Universe in Florida, Disney parks demonstrated resilience, with spending per guest growing 5% in the first quarter of fiscal 2026, offsetting a slight 1% decline in domestic attendance.
With a forward P/E of around 17 and guidance for double-digit earnings growth through 2027, Disney presents itself as a value opportunity in the entertainment sector. Its $60 billion investment plan over the next ten years to expand its parks and cruises should support long-term growth.
Visa: The Global Payments Infrastructure
Visa continues to be one of the most consistent growth stories in the global financial landscape. The stock trades at approximately 25-26 times 2026 forward earnings, a premium justified by the quality of the business: net margins around 50%, return on equity above 50%, and a leadership position in a virtually unassailable duopoly.
2026 promises to be significant for several reasons. First, digital payments have surpassed 50% of global consumer payments for the first time in history, an inflection point that will further accelerate digitalization in emerging markets where Visa has significant growth potential. Second, the company is investing heavily in new areas such as stablecoins, AI-powered payments, and the creator economy through its partnership with Lumanu.
2026 will be the first year in history when half of global consumer payments will be made with card credentials. It's taken a while to get here, but this is a major milestone.
— Visa Corporate InsightsAnalysts maintain a "Strong Buy" rating with an average price target of around $400, implying an upside of 15-20% from current levels. The consensus expects EPS growth of 11-13% annually over the next few years, supported by expansion in cross-border payments, AI-commerce, and B2B.
Exxon Mobil: The Energy Value Play
Exxon Mobil is the energy bet on Barron's list, a stock offering an attractive mix of dividends, buybacks, and potential capital appreciation. With a dividend yield around 3.5% and a $20 billion annual share buyback program, the total shareholder return is significant even without rising oil prices.
Exxon's long-term strategy is based on three pillars: production in Guyana (where new projects like Uaru and Whiptail will come on stream between 2026 and 2027), the Permian Basin, and expansion into LNG with projects like Rovuma in Mozambique and Golden Pass. Diversification also includes the acquisition of Superior Graphite's synthetic graphite assets for the production of EV batteries.
Management raised its earnings growth forecast to $25 billion and cash flow to $35 billion for the 2024-2030 period. With a P/E around 15 and a competitive breakeven point in its main assets, Exxon offers an attractive risk-return profile even in a scenario of moderate oil prices in the $55-$65 per barrel range.
Bristol Myers Squibb: Deep Pharmaceutical Value
Bristol Myers Squibb is perhaps the most controversial pick on the list, trading at just 7-8 times forward earnings, a huge discount compared to the pharmaceutical sector, which averages around 19x. The reason for this squeeze is well known: the company faces significant patent cliffs on Eliquis and Opdivo by the end of the decade.
However, management has implemented several countermeasures. The approval of Opdivo Qvantig, the subcutaneous version of the oncology blockbuster, should mitigate losses when biosimilars enter the market. On the pipeline front, new launches such as Opdualag, Breyanzi, and Reblozyl are gaining traction, with the first two expected to exceed $1 billion in sales by 2025.
Risks to Monitor for Bristol Myers
The growth portfolio currently represents 57% of total revenues with 18% year-over-year growth, but this may not be enough to fully offset the patent cliffs. Debt remains high following recent acquisitions (Karuna, Mirati), and pricing pressures in the US could further compress margins. The stock is only suitable for investors with a high tolerance for volatility.
Two pipeline drugs could be game-changers: Milvexian, a next-generation anticoagulant with estimated sales of up to $6 billion by 2033, and Admilparant for pulmonary fibrosis. With a dividend yield close to 5% and solid free cash flow, BMY could appeal to income-oriented investors seeking contrarian exposure to the healthcare sector.
Flutter Entertainment: The King of Betting USA
FanDuel owner Flutter Entertainment is the only gaming stock on Barron's 2026 list. Despite a challenging 2025, hampered by bettor-friendly NFL results and the emergence of prediction markets, analysts see significant recovery potential.
FanDuel maintains its leadership in the US sports betting market with a market share of over 25%, now operating in 25 states. The launch of FanDuel Predicts, in partnership with CME Group, represents a strategic response to the threat of prediction markets, allowing Flutter to acquire customers even in states where traditional sports betting is not yet legal.
Analysts at HSBC and UBS recently reiterated their Buy ratings, with targets between $228 and $340. The valuation of 20x P/E and 16x EV/EBIT, after factoring in the UK's increased online gaming taxes, appears reasonable for a business with these growth prospects. The main catalyst will be the continued state-by-state liberalization of sports betting in the US.
Comcast: The Value Trap or the Hidden Opportunity?
Comcast is the most debated pick on the list, a stock that has lost about 36% over the past year and is trading at compressed multiples. The bullish thesis is based on the resilience of broadband cash flow, despite the loss of subscribers, and on specific catalysts for 2026.
The first catalyst is the opening of Epic Universe in Orlando in spring 2025, the first major American theme park in decades, which should boost the Experiences segment. The second is Peacock's profitability, expected by 2026, with the streaming platform already having surpassed 40 million paying subscribers.
The analyst consensus calls for an average target of around $35, about 30% above current levels. However, structural challenges in the broadband (competition from 5G fixed wireless and fiber) and traditional television businesses warrant caution. It's a pure value stock, suitable for those who can tolerate volatility while awaiting a revaluation of multiples.
The Complete List: Overview of the 10 Titles
| Ticker | Agency | Sector | Forward P/E | Dividend Yield |
|---|---|---|---|---|
| AMZN | Amazon | Tech / E-commerce | ~29x | — |
| BMY | Bristol Myers Squibb | Healthcare | ~8x | ~4.9% |
| CMCSA | Comcast | Media / Telecom | ~6x | ~5.0% |
| XOM | Exxon Mobil | Energy | ~15x | ~3.5% |
| FFH | Fairfax Financial | Insurance | ~10x | ~1.2% |
| FLUT | Flutter Entertainment | Gaming / Betting | ~20x | — |
| MSGS | Madison Square Garden Sports | Entertainment / Sports | ~35x | — |
| SLG | SL Green Realty | Real Estate / REIT | N/M | ~7.0% |
| V | Visa | Financial Services | ~25x | ~0.8% |
| DIS | Walt Disney | Entertainment | ~17x | ~1.0% |
How to Interpret This List
The distinguishing feature of Barron's 2026 stock picks is their value bias. Five out of ten stocks (Bristol Myers, Comcast, Exxon, Fairfax, and SL Green) have significantly compressed multiples compared to historical averages. This approach reflects a view that, after years of growth outperformance, the best opportunities lie in undervalued companies with specific catalysts for a re-rating.
For Italian investors operating in the US markets, this list offers interesting insights but requires some consideration. Sector diversification is high, ranging from tech (Amazon) to energy (Exxon), healthcare (Bristol Myers) to entertainment (Disney, Flutter), and real estate (SL Green). However, geographic exposure is predominantly American, with the sole exceptions of Fairfax (Canada) and Flutter (Ireland/UK).
Operational Tips
Given the diverse nature of the list, a selective approach seems more appropriate than purchasing the entire basket. The stocks with the best risk-return profile for 2026 appear to be Amazon (due to their AI and cloud exposure), Visa (due to their business quality and earnings visibility), and Disney (due to the combination of compressed valuation and specific catalysts). The more speculative stocks, such as Bristol Myers and SL Green, are only suitable for portfolios with a high risk tolerance.
Final Considerations
Barron's track record deserves respect: the 2025 list beat the S&P 500 by more than 12 percentage points. However, as always in the investing world, past performance does not guarantee future results. The 2026 list carries higher inherent risk than previous years, given its bias toward value stocks with specific catalysts to monitor.
For those who decide to take a position, the advice is to implement a gradual approach, building positions over time and always maintaining careful risk management. 2026 promises to be a year of potential rotation from growth winners towards value appreciation stories, and this list could be a useful guide to navigating this transition.
As always, we encourage you to conduct your own in-depth analysis before making any investment decisions, considering your time horizon, risk tolerance, and specific financial goals. Markets can always surprise, whether positive or negative, and diversification remains the best protection against uncertainty.
